Patvocates’ Post

𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐞𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐢𝐬 𝐢𝐧 𝐨𝐮𝐫 𝐃𝐍𝐀! Earlier this week, we gathered our incredible team from all across Europe for a face-to-face meeting to map out the future direction of Patvocates and the European Patient Advocacy Institute. Over the course of a few days, we analysed our strengths, addressed our weaknesses, brainstormed on new ideas and shared insights of our experienced, diverse team. Our discussions were focused on pushing boundaries in strengthening the patient community, patient engagement and impactful collaboration with healthcare stakeholders. Such a dynamic group of passionate professionals - we are more excited than ever about the road ahead and the important team work we’re collectively doing for patient organisations and healthcare companies. We want to drive meaningful patient engagement and its future with full dedication, deep expertise and a strong commitment to making a difference. A special thanks to everyone who contributed to the inspiring conversations and fun-filled sessions! 👏👏👏 #LetsDoThis #PatientEngagement #FreshPerspectives #TeamCollaboration #FutureFocused

  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
    +3
Angelique Stiassni

Fostering Strong Relationships with Staff | Ensuring Timely AP & AR | Upholding Compliance & Ethical Standards | Budgeting Expertise in Industry & NGOs

2mo

I'm so grateful to be part of this incredible team! Thank you all for your support and everything you've done! 🔝

Congratulations on the successful face-to-face meeting, Patvocates! It's inspiring to see the dedication and commitment of your team in shaping the future of patient advocacy. Keep up the impactful work!

Like
Reply
John K. Solheim

President, European Pulmonary Fibrosis Federation

2mo

Great team Jan Geissler, thank you for being a part of our success.

See more comments

To view or add a comment, sign in

Explore topics